Kamran, Mohammad Zahid <br/><br/>
Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Jun 2013 
 - 399-405 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2013.03.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Cell Line, Tumor<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Neovascularization, Physiologic--drug effects<br/>Pentoxifylline--administration & dosage<br/>Phosphodiesterase Inhibitors--administration & dosage<br/>Phosphorylation--drug effects<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--drug therapy<br/>Tumor Microenvironment--drug effects<br/>Xenograft Model Antitumor Assays